Page last updated: 2024-08-24

atorvastatin and Weight Loss

atorvastatin has been researched along with Weight Loss in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Abdel-Gabbar, M; Abdelaziz, MA; Abdelzaher, MH; Ahmed, OM; Geddawy, AI; Ibrahim, SR; Moawd, SA; Mohammad, MR; Mohideen, AP1
Bangalore, S; DeMicco, DA; Fayyad, R; Laskey, R; Messerli, FH; Waters, DD1
Abtahi Froushani, SM; Delirezh, N; Hobbenaghi, R; Mosayebi, G1
Barter, PJ; DeMicco, DA; Messig, M; Ong, KL; Rye, KA; Waters, DD1
Amniattalab, A; Hobbenaghi, R; Khoramjouy, M; Malekinejad, H1
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z1
Benz, R; Suter, PM1
Athyros, VG; Burroughs, AK; Didangelos, TP; Elisaf, MS; Giouleme, OI; Kakafika, AI; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Tziomalos, K1

Reviews

1 review(s) available for atorvastatin and Weight Loss

ArticleYear
[Low HDL-cholesterol, high triglycerides--well known but often ignored].
    Praxis, 2004, Nov-10, Volume: 93, Issue:46

    Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Cholesterol, HDL; Clofibric Acid; Combined Modality Therapy; Exercise; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Metabolic Syndrome; Niacin; Pyrroles; Risk Factors; Smoking Cessation; Triglycerides; Weight Loss; World Health Organization

2004

Trials

3 trial(s) available for atorvastatin and Weight Loss

ArticleYear
Body-Weight Fluctuations and Outcomes in Coronary Disease.
    The New England journal of medicine, 2017, 04-06, Volume: 376, Issue:14

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Risk Factors; Weight Gain; Weight Loss

2017
Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study).
    The American journal of cardiology, 2014, May-15, Volume: 113, Issue:10

    Topics: Atorvastatin; Body Weight; Coronary Artery Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Global Health; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Style; Male; Middle Aged; Pyrroles; Risk Factors; Time Factors; Weight Loss

2014
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.
    Current medical research and opinion, 2006, Volume: 22, Issue:5

    Topics: Anti-Obesity Agents; Atorvastatin; Diet, Fat-Restricted; Drug Therapy, Combination; Dyslipidemias; Fatty Liver; Female; Fenofibrate; Heptanoic Acids; Humans; Hypolipidemic Agents; Lactones; Male; Metabolic Syndrome; Middle Aged; Orlistat; Prevalence; Prospective Studies; Pyrroles; Risk Factors; Treatment Outcome; Ultrasonography; Weight Loss

2006

Other Studies

5 other study(ies) available for atorvastatin and Weight Loss

ArticleYear
The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:8

    Topics: Animals; Antioxidants; Atorvastatin; Body Weight; Creatinine; Ethylene Glycol; Humans; Hyperoxaluria; Kidney; Male; Oxalates; Polysaccharides; Rats; Rats, Wistar; Ulva; Urea; Uric Acid; Weight Loss

2023
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
    Immunological investigations, 2014, Volume: 43, Issue:1

    Topics: Animals; Atorvastatin; Brain; Cytokines; Disease Models, Animal; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Female; Forkhead Transcription Factors; Heptanoic Acids; Mice; Multiple Sclerosis; Pyrroles; T-Lymphocytes, Regulatory; Tretinoin; Weight Loss

2014
Atorvastatin attenuates the paraquat-induced pulmonary inflammation via PPARĪ³ receptors: a new indication for atorvastatin.
    Pesticide biochemistry and physiology, 2014, Volume: 114

    Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Heptanoic Acids; Herbicides; Interleukin-6; Lung; Male; Malondialdehyde; Nitric Oxide; Paraquat; Peroxidase; Pioglitazone; Pneumonia; PPAR gamma; Pyrroles; Rats, Wistar; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Loss

2014
I've heard that high-fat foods and alcohol can raise triglyceride levels. I take Lipitor for high cholesterol, don't eat high-fat foods and don't drink alcohol except for half a glass of wine a few times a month. My triglycerides are always high when chec
    DukeMedicine healthnews, 2009, Volume: 15, Issue:7

    Topics: Anticholesteremic Agents; Atorvastatin; Exercise; Female; Heptanoic Acids; Humans; Male; Pyrroles; Triglycerides; Weight Loss

2009
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
    Nutrition and cancer, 2012, Volume: 64, Issue:6

    Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss

2012